IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA
The Malaysian experience
(Sprache: Englisch)
Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is...
Leider schon ausverkauft
versandkostenfrei
Buch
49.00 €
24 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA “
Klappentext zu „IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA “
Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients.
Autoren-Porträt von Ping Chong Bee
Bee, Ping ChongI am a senior lecturer and clinical haematologist in University of Malaya, Malaysia. I am also involved in clinical research. My special interest is in chronic myeloid leukaemia.
Bibliographische Angaben
- Autor: Ping Chong Bee
- 2010, 68 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3838355830
- ISBN-13: 9783838355832
Sprache:
Englisch
Kommentar zu "IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA"
0 Gebrauchte Artikel zu „IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA".
Kommentar verfassen